Bufco Vet Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 22-12-2024
- Paid Up Capital ₹ 0.30 M
as on 22-12-2024
- Company Age 2 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Bufco Vet
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Shivam Gupta, Yogesh Gupta, and Ayush Gupta serve as directors at the Company.
- CIN/LLPIN
U24230HR2022PTC103164
- Company No.
103164
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Kurukshetra, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bufco Vet Private Limited offer?
Bufco Vet Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiparasitic Drug, Animal Medicines & Health Care, Veterinary Injections, Veterinary Medicines, Sexual Wellness Products, Fertility Enhancer, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at Bufco Vet?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivam Gupta  | Director | 27-Apr-2022 | Current |
| Yogesh Gupta | Director | 27-Apr-2022 | Current |
| Ayush Gupta | Director | 27-Apr-2022 | Current |
Financial Performance of Bufco Vet.
Enhance accessibility to Bufco Vet's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bufco Vet?
Unlock access to Bufco Vet's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Reticine Pharmaids LimitedActive 19 years 1 monthShivam Gupta, Yogesh Gupta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bufco Vet?
Bufco Vet has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bufco Vet, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bufco Vet's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
